---
figid: PMC5739098__kepi-12-09-1346775-g008
figtitle: Proposed model of changes in epigenetic status before and after establishing
  hiONs from hiPSCs and epigenetic silencing by hyperglycemia in orexin neurons
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5739098
filename: kepi-12-09-1346775-g008.jpg
figlink: /pmc/articles/PMC5739098/figure/f0008/
number: F8
caption: Proposed model of changes in epigenetic status before and after establishing
  hiONs from hiPSCs and epigenetic silencing by hyperglycemia in orexin neurons. (A)
  Epigenetic status in HCRT expressing and non-expressing cells on HCRT gene locus.
  (B) Hexosamine biosynthetic pathway (HBP) and sialic acid synthetic pathway. Some
  glucose is metabolized by the HBP into UDP-GlcNAc, ManNAc, and sialic acid. UDP-GlcNAc
  is used to modify O-GlcNAc in cells, while sialic acid is essential for extracellular
  bioactivity. ManNAc is an intermediate of UDP-GlcNAc and is a precursor of sialic
  acid. ManNFAc, a potent ManNAc derivative, enters the sialic acid biosynthetic pathway,
  while 5S-ManNAc, another potent derivative, does not.
papertitle: Reactivation of hyperglycemia-induced hypocretin (HCRT) gene silencing
  by N-acetyl-d-mannosamine in the orexin neurons derived from human iPS cells.
reftext: Koji Hayakawa, et al. Epigenetics. 2017;12(9):764-778.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9023677
figid_alias: PMC5739098__F8
figtype: Figure
redirect_from: /figures/PMC5739098__F8
ndex: ae82e3f1-deb2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5739098__kepi-12-09-1346775-g008.html
  '@type': Dataset
  description: Proposed model of changes in epigenetic status before and after establishing
    hiONs from hiPSCs and epigenetic silencing by hyperglycemia in orexin neurons.
    (A) Epigenetic status in HCRT expressing and non-expressing cells on HCRT gene
    locus. (B) Hexosamine biosynthetic pathway (HBP) and sialic acid synthetic pathway.
    Some glucose is metabolized by the HBP into UDP-GlcNAc, ManNAc, and sialic acid.
    UDP-GlcNAc is used to modify O-GlcNAc in cells, while sialic acid is essential
    for extracellular bioactivity. ManNAc is an intermediate of UDP-GlcNAc and is
    a precursor of sialic acid. ManNFAc, a potent ManNAc derivative, enters the sialic
    acid biosynthetic pathway, while 5S-ManNAc, another potent derivative, does not.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CycE
  - cyc
  - Sirt1
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - sxc
  - Oga
  - 'On'
  - osa
  - nej
  - ee
  - CAP
  - SMC3
  - Cpn
  - Capa
  - capt
  - bel
  - SERCA
  - Cadps
  - NANS
  - sina
  - GC
  - CBP
  - eIF4E1
  - AZU1
  - HDLBP
  - SLBP
  - STAM2
  - HEBP1
  - SIRT1
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - OGA
  - PLXNA2
  - GNE
  - RENBP
  - EP300
  - CTAA1
  - LNPEP
  - SERPINB6
  - HACD1
  - CAP1
  - SORBS1
  - BRD4
  - CAP2
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - Glucose
  - UDP
---
